KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Non-Current Debt (2020 - 2025)

Historic Non-Current Debt for Regeneron Pharmaceuticals (REGN) over the last 6 years, with Q4 2025 value amounting to $2.0 billion.

  • Regeneron Pharmaceuticals' Non-Current Debt rose 7.56% to $2.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.0 billion, marking a year-over-year increase of 7.56%. This contributed to the annual value of $2.0 billion for FY2025, which is 7.56% up from last year.
  • According to the latest figures from Q4 2025, Regeneron Pharmaceuticals' Non-Current Debt is $2.0 billion, which was up 7.56% from $2.0 billion recorded in Q3 2025.
  • Over the past 5 years, Regeneron Pharmaceuticals' Non-Current Debt peaked at $2.0 billion during Q3 2025, and registered a low of $2.0 billion during Q1 2021.
  • Over the past 5 years, Regeneron Pharmaceuticals' median Non-Current Debt value was $2.0 billion (recorded in 2023), while the average stood at $2.0 billion.
  • Per our database at Business Quant, Regeneron Pharmaceuticals' Non-Current Debt rose by 6.57% in 2021 and then rose by 10.08% in 2025.
  • Over the past 5 years, Regeneron Pharmaceuticals' Non-Current Debt (Quarter) stood at $2.0 billion in 2021, then grew by 0.07% to $2.0 billion in 2022, then increased by 0.08% to $2.0 billion in 2023, then increased by 0.08% to $2.0 billion in 2024, then rose by 0.08% to $2.0 billion in 2025.
  • Its Non-Current Debt was $2.0 billion in Q4 2025, compared to $2.0 billion in Q3 2025 and $2.0 billion in Q2 2025.